Banco Bilbao Vizcaya Argentaria, S.A. (BBVA) is a Spanish multinational bank whose shares trade in the United States as an ADR. Because direct dollar-denominated analyst coverage of the ADR is sparse, the published consensus targets imply only limited upside and fall short of a meaningful 10%-plus objective. The most recent U.S. figures show a mean target near $28.03 from roughly three analysts, while Barron's data list a wider dollar range of about $19.94 to $30.97.
For the euro-listed shares, which represent the same company, a broader pool of about 22 analysts carries an average target near €24.24, in a range of roughly €11.70 to €28.50. The most recent nine-analyst subset averages closer to €25.22, with Jefferies at €27.50 on the high side and UBS at €23.40 on the low side.
Because these consensus figures sit too close to the current price to form a meaningful upside test, this article uses Morningstar's fair-value estimate of $30 per ADR as the central objective. That estimate, published in October 2026, values the bank at about 2.5 times 2026 tangible book value and roughly 12 times expected 2026 earnings per share (EPS). The $30 level also sits just above the highest published dollar targets, making it a credible but demanding benchmark. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The ADR recently traded near $25.53, within a 52-week range of $20.21 to $29.64 and up roughly 15% year to date. Reaching $30 therefore requires about a 17.5% advance from current levels—a substantial move rather than a modest one.
The path would likely depend on continued earnings momentum. BBVA reported record 2025 net attributable profit of about €10.5 billion, up 4.5%, with a return on tangible equity (RoTE) of 19.3%. Through the first nine months of 2026, net profit was reported around €9.07 billion with RoTE near 22%. The ADR carries a trailing P/E (price-to-earnings) ratio of roughly 11 and a forward dividend yield near 4.3%, leaving room for both earnings growth and multiple expansion to contribute to the stock price.
BBVA's Mexican business is its largest earnings engine, and the bank is a market leader in that country. Continued strength there, alongside resilient lending income in Spain and favorable currency trends, has underpinned recent results. Shareholder returns are also substantial: the bank has paired its cash dividend with multi-billion-euro buyback programs, which support per-share value.
On the research side, several firms maintain constructive views. JPMorgan holds an Overweight stance, while Goldman Sachs and Jefferies retain Buy ratings with targets among the highest in the euro-denominated range. A valuation still below many U.S. bank multiples, combined with RoTE in the high-teens to low-20s, gives bulls a case that the stock could re-rate higher.
The risks are meaningful. Mexico accounts for a large share of profits, so peso depreciation would directly reduce dollar-denominated earnings and dividends. BBVA's Turkish operations face high inflation and currency instability, while lower European Central Bank rates could compress net interest income in Spain. Barclays has flagged reduced macro visibility and cut its rating to Neutral, Deutsche Bank downgraded the shares to Hold, and BNP Paribas Exane initiated coverage with a Sell, reflecting skepticism that growth justifies the current valuation.
Uncertainty around the USMCA trade agreement review also adds risk to the Mexican outlook, and regulatory capital requirements (CET1) can limit the pace of buybacks and dividends.
The $30 target sits just above the 52-week high of $29.64, meaning the stock would need to break out to new multi-year highs. That prior high acts as a natural resistance level, while the $25 area and the $20–$21 zone have provided support during recent pullbacks. A decisive move above $29.64, ideally on strong volume, would be the clearest technical signal that the $30 milestone is within reach.
Morningstar's fair-value estimate and most analyst price targets are typically framed over a roughly 12-month horizon, though individual assumptions vary. Investors should watch quarterly results and guidance, with particular attention to Mexican loan growth and peso trends, Turkish inflation, and European net interest margin. Analyst revisions, ECB policy decisions, USMCA developments, and the pace of buybacks are all likely to influence whether the stock can approach $30.
Reaching $30 would require a substantial gain of roughly 17.5% from the recent price near $25.53, and would likely involve a breakout above the 52-week high. The supporting case rests on record profitability, a dominant Mexican franchise, strong returns on tangible equity, and generous shareholder distributions. The opposing case centers on peso and Turkish lira volatility, European rate cuts, trade-policy uncertainty, and a valuation that already reflects much of the good news. With analyst views split between Buy, Hold, and Sell ratings, the $30 objective represents a demanding but identifiable benchmark rather than a forecast. Investors should monitor earnings, currency trends, analyst revisions, and technical resistance near $29.64. From what I see, the technical breakout above recent highs remains the pivotal signal to track.
In my own research process, I often turn to Tickeron's AI Daily Buy/Sell Signals to stay on top of shifting market conditions. These signals use artificial intelligence to monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on technical behavior and broader analysis. For anyone following whether BBVA can sustain momentum toward higher levels, the automated signals provide an efficient way to track changes without constant manual review.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
The RSI Oscillator for BBVA moved out of oversold territory on November 02, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 13 similar instances when the indicator left oversold territory. In 11 of the 13 cases the stock moved higher. This puts the odds of a move higher at 85%.
The Momentum Indicator moved above the 0 level on November 05, 2026. You may want to consider a long position or call options on BBVA as a result. In 61 of 73 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for BBVA just turned positive on November 04, 2026. Looking at past instances where BBVA's MACD turned positive, the stock continued to rise in 37 of 47 cases over the following month. The odds of a continued upward trend are 79%.
Following a +5.75% 3-day Advance, the price is estimated to grow further. Considering data from situations where BBVA advanced for three days, in 251 of 344 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
BBVA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 33 of 60 cases where BBVA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 55%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BBVA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 50%.
The Aroon Indicator for BBVA entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 3 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 4 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 23, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. BBVA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BBVA's P/B Ratio (2.345) is slightly higher than the industry average of (1.500). P/E Ratio (13.254) is within average values for comparable stocks, (11.703). Projected Growth (PEG Ratio) (2.229) is also within normal values, averaging (2.139). BBVA has a moderately high Dividend Yield (0.058) as compared to the industry average of (0.035). P/S Ratio (3.249) is also within normal values, averaging (3.867).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a major bank
Industry MajorBanks